The Food and Drug Administration approved Prezista (darunavir), a new drug developed by Tibotec Pharmaceuticals Ltd. for treatment experienced adults whose infection with the human immunodeficiency virus (HIV) is not responding to treatment with other antiretroviral drugs. Prezista, a protease inhibitor, is indicated to be administered with a low-dose of ritonavir, in combination with other active anti-HIV agents. Ritonavir, which is also a protease inhibitor, slows the metabolism of Prezista...
| Currently you cannot purchase Prezistaa as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Prezistaa |
| Prezistaa Availability Subscription Form |
|
| |
| Note: We will email you when Prezistaa is available for sale online or in pharmacy in your country. |
|
|
|
|